Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 18;11(8):2098. doi: 10.3390/nano11082098

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of R- AgNPs on the cell viability of normal and cancer cells. Bar graph showing dose relationship of R-AgNPs on the viability of two human cancer cell lines; HCT116 () and MDA-MB-231 () and a normal cell line; MCF 10A () (A). Log dose-response relationship of R-AgNPs on the normalised viability of two human cancer cell lines; HCT116 () and MDA-MB-231 () and one normal cell line MCF 10A () (B). IC₅₀ values of AgNPs on each cell line was calculated using Log viability vs. normalised response–variable slope (four-parameter).

Inline graphic — Effect of R- AgNPs on the cell viability of normal and cancer cells. Bar graph showing dose relationship of R-AgNPs on the viability of two human cancer cell lines; HCT116 () and MDA-MB-231 () and a normal cell line; MCF 10A () (A). Log dose-response relationship of R-AgNPs on the normalised viability of two human cancer cell lines; HCT116 () and MDA-MB-231 () and one normal cell line MCF 10A () (B). IC₅₀ values of AgNPs on each cell line was calculated using Log viability vs. normalised response–variable slope (four-parameter).